Based on the downstream Hsa-miR-1533p/CITED2 signaling axis, FGD5-AS1 upregulation could markedly promote GC cell proliferation, chemoresistance, and in vivo tumorigenicity [30,31]. Here, FGD5 is linked to gastric cancer.